NEWMarkets

Nektar Therapeutics (NKTR) Form 4 Filed on June 18 with Details

Published on 6/18/2026

#NKTR#SEC#insider trading#Form 4
Nektar Therapeutics (NKTR) Form 4 Filed on June 18 with Details

AI Summary

Nektar Therapeutics (NKTR) filed a Form 4 on June 18, providing information about recent securities transactions involving its insiders. The filing reveals share transactions that are typically required for reporting due to significant changes in ownership. Such forms are critical for investors as they can indicate insider confidence or actions regarding company shares. The details of this form may influence investor perceptions about NKTR moving forward.

Source: Read original article (opens in new tab)

Related News

Nikkei 225 Futures Rise to 72,030 as Markets Face Mixed Outlook
Markets

Nikkei 225 Futures Rise to 72,030 as Markets Face Mixed Outlook

Jun 18

Aura Minerals Inc (ORA) Form 4 Filing on June 18 Details Changes
Markets

Aura Minerals Inc (ORA) Form 4 Filing on June 18 Details Changes

Jun 18

Xpel Inc (XPEL) Form 4 Report Filed on June 18
Markets

Xpel Inc (XPEL) Form 4 Report Filed on June 18

Jun 18

Sonoma Pharmaceuticals (SNP) Increases At-The-Market Offering to $3.64M
Markets

Sonoma Pharmaceuticals (SNP) Increases At-The-Market Offering to $3.64M

Jun 18